245.07
1.25%
3.02
After Hours:
245.07
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $245.07, with a volume of 1.18M.
It is up +1.25% in the last 24 hours and up +7.63% over the past month.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$242.05
Open:
$243.58
24h Volume:
1.18M
Relative Volume:
0.99
Market Cap:
$47.37B
Revenue:
$293.96B
Net Income/Loss:
$1.51B
P/E Ratio:
32.63
EPS:
7.51
Net Cash Flow:
$3.00B
1W Performance:
+2.09%
1M Performance:
+7.63%
6M Performance:
+9.60%
1Y Performance:
+12.27%
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
COR
Cencora Inc
|
245.07 | 47.37B | 293.96B | 1.51B | 3.00B | 7.51 |
MCK
Mckesson Corporation
|
586.08 | 76.02B | 330.19B | 2.54B | 4.31B | 19.31 |
CAH
Cardinal Health Inc
|
127.83 | 31.14B | 224.34B | 1.26B | 1.08B | 5.14 |
HSIC
Henry Schein Inc
|
74.19 | 8.72B | 12.50B | 314.00M | 421.00M | 2.44 |
PDCO
Patterson Companies Inc
|
30.95 | 2.72B | 6.55B | 155.22M | -823.13M | 1.71 |
Cencora Inc Stock (COR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-04-24 | Resumed | Mizuho | Outperform |
Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Jan-03-24 | Initiated | Barclays | Overweight |
Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
Mar-31-23 | Initiated | Citigroup | Buy |
Jan-31-23 | Resumed | Evercore ISI | Outperform |
Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Apr-01-22 | Resumed | Credit Suisse | Outperform |
Mar-12-21 | Resumed | Evercore ISI | In-line |
Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
Dec-03-20 | Initiated | Mizuho | Neutral |
Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Jul-15-20 | Initiated | Barclays | Underweight |
Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Apr-23-20 | Resumed | Credit Suisse | Outperform |
Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
Sep-12-19 | Initiated | Deutsche Bank | Hold |
Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Apr-11-19 | Initiated | Guggenheim | Buy |
Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
Jan-17-19 | Initiated | UBS | Buy |
Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Sep-20-18 | Initiated | Berenberg | Buy |
Jul-17-18 | Resumed | Stifel | Hold |
Apr-09-18 | Initiated | MoffettNathanson | Buy |
Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
Sep-25-17 | Initiated | JP Morgan | Neutral |
Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
Cencora, Inc. (NYSE:COR) Shares Bought by Merit Financial Group LLC - MarketBeat
Client 1ST Advisory Group LLC Purchases Shares of 2,452 Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora's Quarterly Earnings Preview: What You Need to Know - MSN
J2 Capital Management Inc Invests $639,000 in Cencora, Inc. (NYSE:COR) - MarketBeat
Kera Capital Partners Inc. Invests $258,000 in Cencora, Inc. (NYSE:COR) - MarketBeat
Avanza Fonder AB Purchases New Holdings in Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora, Inc. (NYSE:COR) Stock Holdings Reduced by Wedge Capital Management L L P NC - MarketBeat
1,401 Shares in Cencora, Inc. (NYSE:COR) Bought by Fermata Advisors LLC - MarketBeat
Gateway Investment Advisers LLC Buys 4,555 Shares of Cencora, Inc. (NYSE:COR) - MarketBeat
Park Avenue Securities LLC Raises Stock Holdings in Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora to Release Fiscal Q1 2025 Results, Host Conference Call - MSN
Whizdotai, Inc. announced that it expects to receive $13.999938 million in funding -September 25, 2022 - Marketscreener.com
Eagle Rock Investment Company LLC Boosts Position in Cencora, Inc. (NYSE:COR) - MarketBeat
Occidental Asset Management LLC Boosts Stake in Cencora, Inc. (NYSE:COR) - MarketBeat
Oak Thistle LLC Acquires New Position in Cencora, Inc. (NYSE:COR) - MarketBeat
1,217 Shares in Cencora, Inc. (NYSE:COR) Bought by Miracle Mile Advisors LLC - MarketBeat
Zacks.com featured highlights include The Walt Disney, Leidos, Raymond James Financial, Cencora and Delta Air Lines - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why Cencora (COR) is a Strong Value Stock - Yahoo Finance
Sawyer & Company Inc Has $2.03 Million Position in Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora, Inc. (NYSE:COR) Shares Bought by Thurston Springer Miller Herd & Titak Inc. - MarketBeat
Board of the Pension Protection Fund Invests $989,000 in Cencora, Inc. (NYSE:COR) - MarketBeat
Wright Investors Service Inc. Boosts Stock Position in Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora, Inc. (NYSE:COR) Receives $275.60 Average PT from Analysts - MarketBeat
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
Cencora's SWOT analysis: specialty market leader faces challenges, stock outlook By Investing.com - Investing.com South Africa
Cencora raises 2025 forecast, closes on RCA deal - MSN
Cencora's SWOT analysis: specialty market leader faces challenges, stock outlook - Investing.com
Cencora to Report Q4 Earnings: What's in Store for the Stock? - MSN
Cencora Expands Specialty Leadership with $4.4 Billion Acquisition of Retina Consultants of America - MSN
Here's Why Cencora (COR) is a Strong Momentum Stock - Yahoo Finance
Pharmaceutical Stability And Storage Services Market Projected To Witness Substantial Growth, 2025-2032: - EIN News
Cencora's Quarterly Earnings Preview: What You Need To Know - Barchart
Cencora Sets Q1 2025 Earnings Call: Fortune 500 Pharma Giant to Report February Results - StockTitan
Range Financial Group LLC Increases Position in Cencora, Inc. (NYSE:COR) - MarketBeat
Nordea Investment Management AB Purchases 308,773 Shares of Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora, Inc. (NYSE:COR) Shares Purchased by Insight Wealth Strategies LLC - MarketBeat
Leerink Partnrs Has Positive Outlook for Cencora Q2 Earnings - MarketBeat
MSN - MSN
Cencora Stock May Gain Following the Strategic Acquisition of RCA - Yahoo Finance
Cencora raises EPS outlook after acquiring retina specialist grou By Investing.com - Investing.com Australia
Cencora Completes Retina Consultants of America Acquisition - citybiz
Cencora raises EPS outlook after acquiring retina specialist grou - Investing.com India
Cencora raises 2025 forecast, closes on RCA deal (COR:NYSE) - Seeking Alpha
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):